BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of 186.65 billion as of December 5, 2025. Its market cap has decreased by -21.75% in one year.

Market Cap

186.65B

Enterprise Value

170.76B

Revenue

56.75B

Ranking

n/a

PE Ratio

19.55

Stock Price

980.00

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 4.20B to 186.65B, an increase of 4,340.08%. That is a compound annual growth rate of 15.46%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	186.65B	-28.49%
Dec 31, 2024	261.03B	-14.99%
Dec 29, 2023	307.05B	-18.16%
Dec 30, 2022	375.17B	12.82%
Dec 31, 2021	332.53B	4.98%
Dec 31, 2020	316.75B	10.58%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1,018.35B
Grupo Financiero Banorte	487.26B
Arca Continental	317.94B
Industrias Peñoles	315.30B
GMéxico Transportes	143.33B
FIBRA Prologis	119.35B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	108.97B
Fibra UNO	101.86B

Market Cap Rankings